SCHEMBL4246218

SCHEMBL4246218

O=C(O)C12CN(Cc3ccccc3)CC1c1cccc(C(F)(F)F)c1NC2=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.39
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 2/20 0.39
ATM Q13315 2/20 0.39
GAA P10253 1/20 0.38
NR1I2 O75469 1/20 0.38
RORC P51449 1/20 0.38
P2RX7 Q99572 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
POLB P06746 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
HSD11B1 P28845 1/20 0.36
S1PR1 P21453 1/20 0.36
GRK5 P34947 1/20 0.36
CDK8 P49336 1/20 0.36
S1PR5 Q9H228 1/20 0.36
FAAH O00519 2/20 0.36
BCHE P06276 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4476757 0.99 SIGMAR1 (0.39) SIGMAR1ALDH1A1KDM4EATMGAA
SCHEMBL4481434 0.88 L3MBTL1 (0.41) SIGMAR1ALDH1A1KDM4EATMGAA
SCHEMBL13627296 0.88 L3MBTL1 (0.41) SIGMAR1ALDH1A1KDM4EATMGAA
SCHEMBL4481436 0.88 L3MBTL1 (0.41) SIGMAR1ALDH1A1KDM4EATMGAA
SCHEMBL13627302 0.74 ALDH1A1 (0.43) SIGMAR1ALDH1A1KDM4EATMRORC
SCHEMBL13637321 0.74 ALDH1A1 (0.43) SIGMAR1ALDH1A1KDM4EATMRORC
SCHEMBL4492909 0.74 ALDH1A1 (0.43) SIGMAR1ALDH1A1KDM4EATMRORC
SCHEMBL4492914 0.74 ALDH1A1 (0.43) SIGMAR1ALDH1A1KDM4EATMRORC
SCHEMBL4481729 0.74 ALDH1A1 (0.43) SIGMAR1ALDH1A1KDM4EATMRORC
SCHEMBL4481725 0.74 ALDH1A1 (0.43) SIGMAR1ALDH1A1KDM4EATMRORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7618980-B2 Pyrrolo(oxo)quinolines as 5HT ligands BRISTOL-MYERS SQUIBB COMPANY (US) 2009-11-17 US disclosed
EP-1773833-A4 PYRROLO(OXO)QUINOLINES AS 5HT LIGANDS BRISTOL MYERS SQUIBB CO (US) 2009-07-22 EP disclosed
EP-1773833-A2 PYRROLO(OXO)QUINOLINES AS 5HT LIGANDS Bristol-Myers Squibb Company (US) 2007-04-18 EP disclosed
WO-2006019940-A2 PYRROLO(OXO)QUINOLINES AS 5HT LIGANDS BRISTOL-MYERS SQUIBB COMPANY (US) 2006-02-23 WO disclosed
US-20060014778-A1 (+-)-cis 6-Methoxy-8-phenyl-2,3,3a,4,5,9b-hexahydro-1H-pyrrolo[3,4-c]quinoline; serotonin receptor modulators; obesity, diabetes, atherosclerosis, dyslipidemia; central nervous system diseases like anxiety, depression, OCD, panic disorder, psychosis, schizophrenia, sleep and sexual disorders, BRISTOL-MYERS SQUIBB COMPANY 2006-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060014778-A1 (+-)-cis 6-Methoxy-8-phenyl-2,3,3a,4,5,9b-hexahydro-1H-pyrrolo[3,4-c]quinoline; serotonin receptor modulators; obesity, diabetes, atherosclerosis, dyslipidemia; central nervous system diseases like anxiety, depression, OCD, panic disorder, psychosis, schizophrenia, sleep and sexual disorders, HTR3B, HTR2C, HTR2B SIGMAR1 308/4885ALDH1A1 3212/4885KDM4E 2451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.